Integer (NYSE:ITGR) Price Target Raised to $154.00

Integer (NYSE:ITGRFree Report) had its target price boosted by KeyCorp from $144.00 to $154.00 in a report issued on Friday,Benzinga reports. They currently have an overweight rating on the medical equipment provider’s stock.

Several other research analysts have also recently commented on ITGR. Wells Fargo & Company reiterated an “overweight” rating and issued a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. Piper Sandler reaffirmed an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Bank of America raised their price target on shares of Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. Truist Financial upped their price target on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Finally, Citigroup boosted their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $146.56.

Check Out Our Latest Research Report on Integer

Integer Trading Down 0.3 %

ITGR opened at $142.79 on Friday. The firm’s 50 day moving average is $137.11 and its 200-day moving average is $129.71. Integer has a 52-week low of $94.56 and a 52-week high of $144.22. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $4.79 billion, a P/E ratio of 44.07, a P/E/G ratio of 1.80 and a beta of 1.12.

Integer (NYSE:ITGRGet Free Report) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.27 EPS. Analysts expect that Integer will post 5.33 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. American Century Companies Inc. increased its stake in shares of Integer by 249.7% in the second quarter. American Century Companies Inc. now owns 15,710 shares of the medical equipment provider’s stock valued at $1,819,000 after purchasing an additional 11,218 shares during the period. Hsbc Holdings PLC increased its position in Integer by 123.3% in the 2nd quarter. Hsbc Holdings PLC now owns 6,458 shares of the medical equipment provider’s stock valued at $745,000 after acquiring an additional 3,566 shares during the period. Xponance Inc. raised its stake in Integer by 4.9% during the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock valued at $245,000 after acquiring an additional 99 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in Integer by 7.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 180,862 shares of the medical equipment provider’s stock worth $20,942,000 after acquiring an additional 11,856 shares during the period. Finally, Lighthouse Investment Partners LLC grew its stake in shares of Integer by 240.4% in the second quarter. Lighthouse Investment Partners LLC now owns 32,398 shares of the medical equipment provider’s stock worth $3,751,000 after purchasing an additional 22,881 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

(Get Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

See Also

Analyst Recommendations for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.